Interrupting this link using RNAi against cytosolic alanine transaminase (GPT2) was demonstrated to impair oxygen metabolism, cell proliferation, and tumor growth in colon cancer [57]. The gene discussed is GPT2; the disease is malignant colon neoplasm.